When will the Ottava robot be available?

J&J has not announced a specific launch date but plans to offer it to select customers initially.

How will Ottava compete with Intuitive Surgical's Da Vinci?

Ottava will compete with Da Vinci through its modular design offering greater flexibility, but it faces Da Vinci's strong market dominance.

What does FDA clearance mean for J&J stock?

The clearance is a strategic step to boost the MedTech division and could support long-term revenue growth, but the immediate stock impact depends on commercial launch success.

J&J Enters Surgical Robot Race as Ottava Gets FDA Nod

Johnson & Johnson's Ottava surgical robot has received FDA clearance through the De Novo pathway. The company plans to launch with select customers without disclosing a specific timeline.

July 22, 2026

2 min read

Source: Medical Device Network

Johnson & Johnson (JNJ) has received FDA clearance for its Ottava surgical robot via the De Novo pathway, marking its entry into the competitive robotic surgery market.

The Product

Ottava is a multi-arm surgical robot designed for minimally invasive procedures. It features a modular design for greater flexibility in the operating room, aiming to improve surgical precision and reduce patient recovery time.

Pricing and Availability

J&J has not disclosed pricing or a specific launch timeline. However, the company initially plans to offer Ottava to "select customers" only.

Competition

Ottava enters a market dominated by Intuitive Surgical's Da Vinci system, which is used in over 10 million procedures annually. Competitors also include Medtronic and Stryker, who are developing their own robotic platforms.

Potential Impact on J&J

Entering the surgical robotics space is a strategic move for J&J to bolster its MedTech division. Ottava could help capture market share in the medical devices sector, but it faces stiff competition from established players.

Frequently Asked Questions

Ottava is a multi-arm surgical robot developed by Johnson & Johnson for minimally invasive procedures, aiming to improve surgical precision and reduce recovery time.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.